Funding for this research was provided by:
National Key Research and Development Program of China (2016YFC1000306)
Received: 20 January 2019
Accepted: 11 August 2019
First Online: 27 August 2019
Ethics approval and consent to participate
: This study was approved by the human ethics committees of the Affiliated Hospital of Qingdao University.
: Written informed consent was obtained from both the patient’s legal guardian (his parents) to participate in this study and for the publication of the details and genetic sequencing of the case report.
: The authors declare that they have no competing interests.